Who’s filing patents in the nuclear energy industry

April 4, 2022
# min read

GLOBAL PATENT LANDSCAPE

When looking at the global patent landscape, we found 763 applicants and 1,295 patents in the nuclear energy space, across 19 countries. China dominates the industry, with 518 applicants, followed by Russia, with 65.

Across the board, applicants saw an uptick in patent filings within the nuclear energy space in 2019, that has increased steadily since then.

The top 3 global patent players are: UNIV XI AN JIAOTONG (36 patents), UNIV HARBIN ENG (17 patents), and SHANGHAI NUCLEAR ENG RES & DESIGN INST CO LTD (17 patents).

The two most recent patents filed in nuclear energy were by TerraPower, for:
Heat Exchanger Configuration for Nuclear Reactor; and
Passive Heat Removal System for Nuclear Reactors

The third most recent patent was filed by Beam Alpha Inc. for a Sulfur Blanket.

U.S. PATENT LANDSCAPE

cypris ai US patent landscape image

The U.S. patent market, specifically, has experienced a 18.39% average growth rate over the past 5 years. The highest annual increase came in 2018, when TerraPower filed 5 new patents within the space.

Notably, 5.99% of the market is owned by 3 key players: Schlumberger Limited, Siemens Aktiengesellschaft, and Baker Hughes.

Technologies referencing the key words “neutrons” and “fission” have experienced the steepest increase since 2017.

Looking to gain market intelligence on your area of focus? Visit ipcypris.com to get started. Explore recently filed patents for free via the global patent search engine.

Similar insights you might enjoy

11 Best AI Tools for Scientific Literature Review in 2026

This comprehensive guide examines the leading AI-powered scientific literature review tools available in 2026, analyzing their capabilities, data coverage, and suitability for different research workflows. The analysis distinguishes between academic-focused free platforms serving thesis development and enterprise R&D intelligence systems that combine patent analysis with scientific literature for competitive technology intelligence. With over 5.14 million academic papers published annually, AI literature review tools have become essential infrastructure for managing research at scale, though tools vary dramatically in their ability to serve corporate strategic decision-making versus academic publication support.

11 Best AI Tools for Scientific Literature Review in 2026

This comprehensive guide examines the leading AI-powered scientific literature review tools available in 2026, analyzing their capabilities, data coverage, and suitability for different research workflows. The analysis distinguishes between academic-focused free platforms serving thesis development and enterprise R&D intelligence systems that combine patent analysis with scientific literature for competitive technology intelligence. With over 5.14 million academic papers published annually, AI literature review tools have become essential infrastructure for managing research at scale, though tools vary dramatically in their ability to serve corporate strategic decision-making versus academic publication support.

From Co-Pilot to Lab-Pilot: How Agentic AI is Redefining Chemical R&D

The chemical industry is transitioning from reactive generative AI tools to autonomous agentic AI systems capable of planning, executing, and iterating on multi-step scientific workflows with minimal human oversight. Self-driving laboratories like LUMI-lab are already operational, with one platform synthesizing and evaluating over 1,700 lipid nanoparticles across ten iterative cycles and discovering novel delivery mechanisms that emerged from autonomous exploration rather than human hypothesis. Major chemical companies including BASF, Dow, and SABIC are building proprietary AI infrastructure as evidenced by patent filings for machine learning-driven formulation prediction, protein engineering pipelines, and AI-based process control systems.

From Co-Pilot to Lab-Pilot: How Agentic AI is Redefining Chemical R&D

The chemical industry is transitioning from reactive generative AI tools to autonomous agentic AI systems capable of planning, executing, and iterating on multi-step scientific workflows with minimal human oversight. Self-driving laboratories like LUMI-lab are already operational, with one platform synthesizing and evaluating over 1,700 lipid nanoparticles across ten iterative cycles and discovering novel delivery mechanisms that emerged from autonomous exploration rather than human hypothesis. Major chemical companies including BASF, Dow, and SABIC are building proprietary AI infrastructure as evidenced by patent filings for machine learning-driven formulation prediction, protein engineering pipelines, and AI-based process control systems.